<DOC>
	<DOCNO>NCT00464282</DOCNO>
	<brief_summary>Objective : L- [ 3-18F ] -α–methyltyrosine ( FMT ) amino-acid tracer PET . We evaluate diagnostic usefulness 18F-FMT PET non-small cell lung cancer ( NSCLC ) patient . Tumor uptake 18F-FMT PET compare 18F-FDG PET correlation L-type amino acid transporter 1 ( LAT1 ) expression also investigate . Method : Fifty patient NSCLC enrol study , pair PET study 18F-FMT 18F-FDG performed . LAT1 expression Ki-67 labeling index resect tumor analyze immunohistochemical study .</brief_summary>
	<brief_title>Fluorine-18-α–Methyltyrosine Positron Emission Tomography Diagnosis Staging Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>proven suspect nonsmall cell lung cancer uncontrolled diabetes mellitus</criteria>
	<gender>All</gender>
	<minimum_age>8 Months</minimum_age>
	<maximum_age>2 Years</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>Fluorine–18-α–methyltyrosine ,</keyword>
	<keyword>Positron emission tomography ,</keyword>
	<keyword>Fluorodeoxyglucose</keyword>
	<keyword>Lung cancer ,</keyword>
	<keyword>Amino acid transportor 1 ,</keyword>
	<keyword>Ki-67</keyword>
	<keyword>Proven suspect non-small cell lung cancer enrol study</keyword>
</DOC>